JKTG Founder and President Ted Giovanis, leading researchers, and University leaders gathered at the Johns Hopkins Welch Medical Library this week to formally mark the dedication of the Giovanis Institute for Translational Cell Biology – a symbolic first step of this important cancer research program.
Through a $35M, 15-year gift from Giovanis, researchers will tackle the most fatal aspect of cancer: how it metastasizes, or spreads, through the body. Key to this work is collaboration among many disciplines, including biology, clinical treatment of patients, physics, engineering, machine learning, and computational medicine.
“I strongly believe that tackling hard questions and inviting collaboration across disciplines empowers new thinking among researchers who, I believe, can transform how we diagnose and treat cancer,” said Giovanis.
Featured news
Ted’s Take: SDOH meet BMI
Social Determinants of Health (SDoH) is all the rage as far as evaluating health. Stable housing, education, access to transportation, polluted water/air, etc. are all an important part of the discussion.
Ted’s Take: TG not in Part C
Medicare Part C, sometimes called Medicare Advantage, is touted as the efficient way to deliver quality care to enrollees. As someone on Medicare, I am not in a Medicare Part C. Why? Because I know better.
Ted’s Take: Ted’s Take: Coalescing or Convergent Thinking
I’d like to introduce the concept that coalescing or “convergent thinking” may be detrimental within an organizational setting. By this, I mean that individuals working in the same or similar space often tend to think similar thoughts.
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133